Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization

International Journal of Hematology

Volumn 77, Issue 1, 2003, Pages 75-81

  Watanabe, Tsutomu ^a   Suzuya, Hiroko ^a   Onishi, Toshihiro ^a   Kanai, Sachiyo ^a   Kaneko, Michiya ^a   Watanabe, Hiroyoshi ^a   Nakagawa, Ryuji ^a   Kawano, Yoshifumi ^b   Takaue, Yoichi ^c   Kuroda, Yasuhiro ^a   Talmadge, James E ^d  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bone metabolism; G CSF; Mobilization; Peripheral blood stem cells

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CD34 ANTIGEN; COLONY STIMULATING FACTOR 1; CREATININE; CYTOKINE; DEOXYPYRIDINOLINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOPROTEGERIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AMINO ACID; BIOLOGICAL MARKER; GRANULOCYTE COLONY STIMULATING FACTOR; OSTEOCALCIN;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; APHERESIS; ARTICLE; BLOOD SAMPLING; BONE METABOLISM; CHILD; CREATININE BLOOD LEVEL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELL; HUMAN; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; STEM CELL; URINE LEVEL; BLOOD; BONE REMODELING; CLINICAL TRIAL; DRUG EFFECT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE REMODELING; CHILD; CHILD, PRESCHOOL; CYTOKINES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; OSTEOCALCIN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 0038651197     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982606     Document Type: Article

References (31)

1. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89:2233-2258.
2. Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood. 1996;88:2819-2825.
3. + immunoselection. J Clin Oncol. 1999;17:2160-2172.
4. de la Rubin J, Martínez C, Solano C, et al. Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBT. Bone Marrow Transplant. 1999;24:723-728.
5. Snowden JA, Biggs JC, Milliken ST, et al. A randomized, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for hematopoietic stem cell mobilization in patients with severe active rheumatoid arthritis. Bone Marrow Transplant. 1998;22:1035-1041.
6. Bishop NJ, Williams DM, Compston JC, et al. Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol. 1995;89:927-928.
7. Takahashi T, Wada T, Mori M, et al. Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice. Lab Invest. 1996;74:827-834.
8. Lee MY, Fukunaga R, Lee TJ, et al. Bone modulation in sustained hematopoietic stimulation in mice. Blood. 1991;77:2135-2141.
9. Papayannopoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci U S A. 1993;90:9374-9378.
10. Lévesque JP, Leavesley DI, Niutta S, et al. Cytokines increase human hematopoietic cell adhesiveness by activation of very late antigen (VLA) -4 and VLA-5 integrins. J Exp Med. 1995;181:1805-1815.
11. + cells across uncoated or fibronectin-coated filters. Exp Hematol. 1999;27:1806-1814.
12. Petit I, Szyper-Kravitz M, Naglar A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3:687-694.
13. + progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. Exp Hematol. 1995;23:1535-1542.
14. Watanabe T, Kawano Y, Kanamaru S, et al. Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Blood. 1999;93:1157-1163.
15. Roodman GD. Cell biology of the osteoclast. Exp Hematol. 1999;27:1229-1241.
16. Jimi E, Shuto T, Koga T. Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells. Endocrinology. 1995;136:808-811.
17. Fuller K, Owens JM, Jagger CJ, et al. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med. 1993;178:1733-1744.
18. Pfeilschifter J, Chenu C, Bird A, et al. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res. 1989;4:113-118.
19. Murray RE, McGuigan F, Grant SF, et al. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone. 1997;21:89-92.
20. Zhou H, Choong PC, Chou ST, et al. Transforming growth factor beta 1 stimulates bone formation 'and resorption in an in-vitro model in rabbits. Bone. 1995;17:443S-448S.
21. Fujita T, Mastui T, Nakao Y, et al. Cytokines and osteoporosis. Ann N Y Acad Sci. 1990;587:371-375.
22. Yasuda H, Shima N, Nakagawa N, et al. Identify of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 1998;139:1329-1337.
23. Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res. 1993;8(suppl 2):S549-S555.
24. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9-mediated release of kit-ligand. Cell. 2002;109:625-637.
25. + cells in response to chemokines. Exp Hematol. 2000;28:1274-1285.
26. Lévesque JP, Takamatsu Y, Nilsson S, Haylock DN, Simmons PJ. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood. 2001;98:1289-1297.
27. Bonilla MA, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994;88:723-730.
28. Soshi S, Takahashi HE, Tanizawa T, et al. Effects of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on rat bone: inhibition of bone formation at the endosteal surface of vertebra and tibia. Calcif Tissue Int. 1996;58:337-340.
29. Morris HA, Chatterton BE, Ross PD, Durbridge TC. Diagnostic procedures. In: Need AG, Morris HA, eds. Metabolic Bone and Stone Disease. Edinburgh, UK: Churchill Livingstone; 1993:339-379.
30. Takamatsu Y, Simmons PJ, Moore RJ, et al. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood. 1998;92:3465-3473.
31. Shinar DM, Sato M, Rodan GA. The effect of hematopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures. Endocrinology. 1990;126:1728-1735.